These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 26192592)
21. Neutralization of negative charges of siRNA results in improved safety and efficient gene silencing activity of lipid nanoparticles loaded with high levels of siRNA. Sato Y; Matsui H; Sato R; Harashima H J Control Release; 2018 Aug; 284():179-187. PubMed ID: 29936118 [TBL] [Abstract][Full Text] [Related]
22. F127/Calcium phosphate hybrid nanoparticles: a promising vector for improving siRNA delivery and gene silencing. Qin L; Sun Y; Liu P; Wang Q; Han B; Duan Y J Biomater Sci Polym Ed; 2013; 24(15):1757-66. PubMed ID: 23746331 [TBL] [Abstract][Full Text] [Related]
23. pH-labile PEGylation of siRNA-loaded lipid nanoparticle improves active targeting and gene silencing activity in hepatocytes. Hashiba K; Sato Y; Harashima H J Control Release; 2017 Sep; 262():239-246. PubMed ID: 28774839 [TBL] [Abstract][Full Text] [Related]
24. Probing milk extracellular vesicles for intestinal delivery of RNA therapies. Zhang Y; Belaid M; Luo X; Daci A; Limani R; Mantaj J; Zilbauer M; Nayak K; Vllasaliu D J Nanobiotechnology; 2023 Nov; 21(1):406. PubMed ID: 37924132 [TBL] [Abstract][Full Text] [Related]
25. Quantitation of physiological and biochemical barriers to siRNA liver delivery via lipid nanoparticle platform. Xu Y; Ou M; Keough E; Roberts J; Koeplinger K; Lyman M; Fauty S; Carlini E; Stern M; Zhang R; Yeh S; Mahan E; Wang Y; Slaughter D; Gindy M; Raab C; Thompson C; Hochman J Mol Pharm; 2014 May; 11(5):1424-34. PubMed ID: 24588618 [TBL] [Abstract][Full Text] [Related]
26. Engineering of Solid Dosage Forms of siRNA-Loaded Lipidoid-Polymer Hybrid Nanoparticles Using a Quality-by-Design Approach. Lokras A; Foged C; Thakur A Methods Mol Biol; 2021; 2282():137-157. PubMed ID: 33928574 [TBL] [Abstract][Full Text] [Related]
28. Small-sized, stable lipid nanoparticle for the efficient delivery of siRNA to human immune cell lines. Nakamura T; Kuroi M; Fujiwara Y; Warashina S; Sato Y; Harashima H Sci Rep; 2016 Nov; 6():37849. PubMed ID: 27892533 [TBL] [Abstract][Full Text] [Related]
29. Silencing TNFα with lipidoid nanoparticles downregulates both TNFα and MCP-1 in an in vitro co-culture model of diabetic foot ulcers. Kasiewicz LN; Whitehead KA Acta Biomater; 2016 Mar; 32():120-128. PubMed ID: 26689461 [TBL] [Abstract][Full Text] [Related]
30. Retinoic Acid Facilitates Toll-Like Receptor 4 Expression to Improve Intestinal Barrier Function through Retinoic Acid Receptor Beta. Li Y; Gao Y; Cui T; Yang T; Liu L; Li T; Chen J Cell Physiol Biochem; 2017; 42(4):1390-1406. PubMed ID: 28715808 [TBL] [Abstract][Full Text] [Related]
31. Cosilencing Intestinal Transglutaminase-2 and Interleukin-15 Using Gelatin-Based Nanoparticles in an in Vitro Model of Celiac Disease. Attarwala H; Clausen V; Chaturvedi P; Amiji MM Mol Pharm; 2017 Sep; 14(9):3036-3044. PubMed ID: 28737923 [TBL] [Abstract][Full Text] [Related]
32. A simple, noninvasive and efficient method for transdermal delivery of siRNA. Lin CM; Huang K; Zeng Y; Chen XC; Wang S; Li Y Arch Dermatol Res; 2012 Mar; 304(2):139-44. PubMed ID: 22009459 [TBL] [Abstract][Full Text] [Related]
33. Lipidoid-polymer hybrid nanoparticles loaded with TNF siRNA suppress inflammation after intra-articular administration in a murine experimental arthritis model. Jansen MAA; Klausen LH; Thanki K; Lyngsø J; Skov Pedersen J; Franzyk H; Nielsen HM; van Eden W; Dong M; Broere F; Foged C; Zeng X Eur J Pharm Biopharm; 2019 Sep; 142():38-48. PubMed ID: 31199978 [TBL] [Abstract][Full Text] [Related]
34. Achieving long-term stability of lipid nanoparticles: examining the effect of pH, temperature, and lyophilization. Ball RL; Bajaj P; Whitehead KA Int J Nanomedicine; 2017; 12():305-315. PubMed ID: 28115848 [TBL] [Abstract][Full Text] [Related]
35. Highly specific delivery of siRNA to hepatocytes circumvents endothelial cell-mediated lipid nanoparticle-associated toxicity leading to the safe and efficacious decrease in the hepatitis B virus. Sato Y; Matsui H; Yamamoto N; Sato R; Munakata T; Kohara M; Harashima H J Control Release; 2017 Nov; 266():216-225. PubMed ID: 28986168 [TBL] [Abstract][Full Text] [Related]
36. Vascular endothelial growth factor-C siRNA delivered via calcium carbonate nanoparticle effectively inhibits lymphangiogenesis and growth of colorectal cancer in vivo. He XW; Liu T; Xiao Y; Feng YL; Cheng DJ; Tingting G; Zhang L; Zhang Y; Chen YX; Tingting G; Zhang L Cancer Biother Radiopharm; 2009 Apr; 24(2):249-59. PubMed ID: 19409048 [TBL] [Abstract][Full Text] [Related]
37. Novel epithelial cell adhesion molecule antibody conjugated polyethyleneimine-capped gold nanoparticles for enhanced and targeted small interfering RNA delivery to retinoblastoma cells. Mitra M; Kandalam M; Rangasamy J; Shankar B; Maheswari UK; Swaminathan S; Krishnakumar S Mol Vis; 2013; 19():1029-38. PubMed ID: 23687439 [TBL] [Abstract][Full Text] [Related]
38. Elevated expression of forkhead box protein O1 (FoxO1) in alcohol-induced intestinal barrier dysfunction. Wang Y; Tong J; Zou D; Chang B; Wang B; Wang B Acta Histochem; 2013 Jul; 115(6):557-63. PubMed ID: 23347700 [TBL] [Abstract][Full Text] [Related]
39. Lipid nanoparticles for hepatic delivery of small interfering RNA. Yu B; Hsu SH; Zhou C; Wang X; Terp MC; Wu Y; Teng L; Mao Y; Wang F; Xue W; Jacob ST; Ghoshal K; Lee RJ; Lee LJ Biomaterials; 2012 Sep; 33(25):5924-34. PubMed ID: 22652024 [TBL] [Abstract][Full Text] [Related]
40. Airway epithelial cell-specific delivery of lipid nanoparticles loading siRNA for asthma treatment. Zhang M; Jiang H; Wu L; Lu H; Bera H; Zhao X; Guo X; Liu X; Cun D; Yang M J Control Release; 2022 Dec; 352():422-437. PubMed ID: 36265740 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]